Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice

Behavioral Neuroscience

Volumn 120, Issue 2, 2006, Pages 249-256

  Ardayfio, Paul ^a   Kim, Kwang Soo ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Anxiety; Cortisol; Depression

Indexed keywords

CORTICOSTERONE; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CUSHING DISEASE; DEPRESSION; FEMALE; HABITUATION; HYPERCORTISOLISM; LATENT PERIOD; LIGHT DARK CYCLE; MEASUREMENT; MOOD DISORDER; MOUSE; MOUSE STRAIN; NONHUMAN; STARTLE REFLEX; SYMPTOM; TASK PERFORMANCE;

ADRENOCORTICAL HYPERFUNCTION; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; MICE; REACTION TIME; STARTLE REACTION; STATISTICS, NONPARAMETRIC; TASK PERFORMANCE AND ANALYSIS;

EID: 33744477075     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.120.2.249     Document Type: Article

References (79)

1. Andreatini, R., & Leite, J. R. (1994). The effect of corticosterone in rats submitted to the elevated plus-maze and to pentylenetetrazol-induced convulsions. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 18, 1333-1347.
2. Ardayfio, P., & Kim, K. S. (2004). [Enhanced freezing in the light-dark box after anxiogenic treatments]. Unpublished observations.
3. Bannon, A. W., Seda, J., Carmouche, M., Francis, J. M., Norman, M. H., Karbon, B., et al. (2000). Behavioral characterization of neuropeptide Y knockout mice. Brain Research, 868, 79-87.
4. Belzung, C., & Griebel, G. (2001). Measuring normal and pathological anxiety-like behaviour in mice: A review. Behavioural Brain Research, 125, 141-149.
5. Bilkei-Gorzo, A., Gyertyan, I., & Levay, G. (1998). mCPP-induced anxiety in the light-dark box in rats - a new method for screening anxiolytic activity. Psychopharmacology, 136, 291-298.
6. Buchanan, T. W., Brechtel, A., Sollers, J. J., & Lovallo, W. R. (2001). Exogenous cortisol exerts effects on the startle reflex independent of emotional modulation. Pharmacology Biochemistry and Behavior, 68, 203-210.
7. Cloninger, C. R. (1990). Comorbidity of anxiety and depression. Journal of Clinical Psychopharmacology, 10(Suppl. 3), 43S-46S.
8. Conrad, C. D., MacMillan, D. D., II, Tsekhanov, S., Wright, R. L., Baran, S. E., & Fuchs, R. A. (2004). Influence of chronic corticosterone and glucocorticoid receptor antagonism in the amygdala on fear conditioning. Neurobiology of Learning and Memory, 81, 185-199.
9. Corodimas, K. P., LeDoux, J. E., Gold, P. W., & Schulkin, J. (1994). Corticosterone potentiation of conditioned fear in rats. In E. R. de Kloet, E. C. Azmitia, & P. W. Landfield (Eds.), Annals of the New York Academy of Sciences: Vol. 746. Brain corticosteroid receptors: Studies on the mechanism, function, and neurotoxicity of corticosteroid action (pp. 392-393). New York: New York Academy of Sciences.
10. Crawley, J. N. (1981). Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacology Biochemistry and Behavior, 15, 695-699.
11. Crawley, J. N. (1985). Exploratory behavior models of anxiety in mice. Neuroscience & Biobehavioral Reviews, 9, 37-44.
12. Desousa, N. J., Wunderlich, G. R., De Cabo, C., & Vaccarino, F. J. (1998). Individual differences in sucrose intake predict behavioral reactivity in rodent models of anxiety. Pharmacology Biochemistry and Behavior, 60, 841-846.
13. de Winter, R. F., van Hemert, A. M., DeRijk, R. H., Zwinderman, K. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., et al. (2003). Anxious-retarded depression: Relation with plasma vasopressin and cortisol. Neuropsychopharmacology, 28, 140-147.
14. Dirks, A., Groenink, L., Schipholt, M. I., van der Gugten, J., Hijzen, T. H., Geyer, M. A., et al. (2002). Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biological Psychiatry, 51, 583-590.
15. Drevets, W. C., Price, J. L., Bardgett, M. E., Reich, T., Todd, R. D., & Raichle, M. E. (2002). Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacology Biochemistry and Behavior, 71, 431-447.
16. Erickson, K., Drevets, W., & Schulkin, J. (2003). Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neuroscience & Biobehavioral Reviews, 27, 233-246.
17. Fairchild, G., Leitch, M. M., & Ingram, C. D. (2003). Acute and chronic effects of corticosterone on 5-HT1A receptor-mediated autoinhibition in the rat dorsal raphe nucleus. Neuropharmacology, 45, 925-934.
18. Fava, G. A. (1994). Affective disorders and endocrine disease. New insights from psychosomatic studies. Psychosomatics, 35, 341-353.
19. Fava, G. A., Sonino, N., & Morphy, M. A. (1987). Major depression associated with endocrine disease. Psychiatric Developments, 5, 321-348.
20. Fernandez, F., Misilmeri, M. A., Felger, J. C., & Devine, D. P. (2004). Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology, 29, 59-71.
21. Ferrari, P. F., Palanza, P., Parmigiani, S., & Rodgers, R. J. (1998). Interindividual variability in Swiss male mice: Relationship between social factors, aggression, and anxiety. Physiology & Behavior, 63, 821-827.
22. Flint, J. (2001). Is this mouse anxious? The difficulties of interpreting the effects of genetic action. Commentary on Belzung "The genetic basis of the pharmacological effects of anxiolytics" and Olivier et al. "The 5-HT(1A) receptor knockout mouse and anxiety". Behavioural Pharmacology, 12(6-7), 461-465.
23. Gillespie, C. F., & Nemeroff, C. B. (2005). Hypercortisolemia and depression. Psychosomatic Medicine, 67(Suppl. 1), S26-S28.
24. Glowa, J. R., Geyer, M. A., Gold, P. W., & Sternberg, E. M. (1992). Differential startle amplitude and corticosterone response in rats. Neuroendocrinology, 56, 719-723.
25. Gonzalez-Perez, O., Ramos-Remus, C., Garcia-Estrada, J., & Luquin, S. (2001). Prednisone induces anxiety and glial cerebral changes in rats. Journal of Rheumatology, 28, 2529-2534.
26. Gregus, A., Wintink, A. J., Davis, A. C., & Kalynchuk, L. E. (2005). Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behavioural Brain Research, 156, 105-114.
27. Grillon, C. (2002). Startle reactivity and anxiety disorders: Aversive conditioning, context, and neurobiology. Biological Psychiatry, 52, 958-975.
28. Grillon, C., & Baas, J. (2003). A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clinical Neurophysiology, 114, 1557-1579.
29. Huang, G. J., & Herbert, J. (2005). Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult rat. Neuropsychopharmacology, 30, 231-241.
30. Hui, G. K., Figueroa, I. R., Poytress, B. S., Roozendaal, B., McGaugh, J. L., & Weinberger, N. M. (2004). Memory enhancement of classical fear conditioning by post-training injections of corticosterone in rats. Neurobiology of Learning and Memory, 81, 67-74.
31. Imaizumi, M., Miyazaki, S., & Onodera, K. (1994). Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors. Methods and Findings in Experimental and Clinical Pharmacology, 16, 639-644.
32. Inoue, T., & Koyama, T. (1996). Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20, 147-156.
33. Jonkman, S., Henry, B., Semenova, S., & Markou, A. (2005). Mild anxiogenic effects of nicotine withdrawal in mice. European Journal of Pharmacology, 516, 40-45.
34. Kalynchuk, L. E., Gregus, A., Boudreau, D., & Perrot-Sinal, T. S. (2004). Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behavioral Neuroscience, 118, 1365-1377.
35. Kaviani, H., Gray, J. A., Checkley, S. A., Raven, P. W., Wilson, G. D., & Kumari, V. (2004). Affective modulation of the startle response in depression: Influence of the severity of depression, anhedonia, and anxiety. Journal of Affective Disorders, 83, 21-31.
36. Kayani, S., & Shannon, D. C. (2002). Adverse behavioral effects of treatment for acute exacerbation of asthma in children: A comparison of two doses of oral steroids. Chest, 122, 624-628.
37. Kelly, W. F. (1996). Psychiatric aspects of Cushing's syndrome. QJM, 89, 543-551.
38. Kendler, K. S., Eaves, L. J., Walters, E. E., Neale, M. C., Heath, A. C., & Kessler, R. C. (1996). The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Archives of General Psychiatry, 53, 391-399.
39. Loosen, P. T., Chambliss, B., DeBold, C. R., Shelton, R., & Orth, D. N. (1992). Psychiatric phenomenology in Cushing's disease. Pharmacopsychiatry, 25, 192-198.
40. Magarinos, A. M., Orchinik, M., & McEwen, B. S. (1998). Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: A paradox. Brain Research, 809, 314-318.
41. Makino, S., Gold, P. W., & Schulkin, J. (1994a). Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Research, 640, 105-112.
42. Makino, S., Gold, P. W., & Schulkin, J. (1994b). Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Research, 657, 141-149.
43. Malmberg-Aiello, P., Ipponi, A., Bartolini, A., & Schunack, W. (2002). Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacology Biochemistry and Behavior, 71, 313-318.
44. Mannuzza, S., Fyer, A. J., Martin, L. Y., Gallops, M. S., Endicott, J., Gorman, J., et al. (1989). Reliability of anxiety assessment. I. Diagnostic agreement. Archives of General Psychiatry, 46, 1093-1101.
45. Marshall, R. D., & Garakani, A. (2002). Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder. Psychiatric Clinics of North America, 25, 385-395.
46. McEwen, B. S. (2003). Mood disorders and allostatic load. Biological Psychiatry, 54, 200-207.
47. Milde, A. M., Sundberg, H., Roseth, A. G., & Murison, R. (2003). Proactive sensitizing effects of acute stress on acoustic startle responses and experimentally induced colitis in rats: Relationship to corticosterone. Stress, 6, 49-57.
48. Munck, A., Guyre, P. M., & Holbrook, N. J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Reviews, 5, 25-44.
49. Nacher, J., Gomez-Climent, M. A., & McEwen, B. (2004). Chronic non-invasive glucocorticoid administration decreases polysialylated neural cell adhesion molecule expression in the adult rat dentate gyrus. Neuroscience Letters, 370, 40-44.
50. Nemeroff, C. B., & Evans, D. L. (1984). Correlation between the dexamethasone suppression test in depressed patients and clinical response. American Journal of Psychiatry, 141, 247-249.
51. Onaivi, E. S., & Martin, B. R. (1989). Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 13, 963-976.
52. Onaivi, E. S., Todd, S., & Martin, B. R. (1989). Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration. Drug and Alcohol Dependence, 24, 205-211.
53. Paterson, A., Whiting, P. J., Gray, J. A., Flint, J., & Dawson, G. R. (2001). Lack of consistent behavioural effects of Maudsley reactive and non-reactive rats in a number of animal tests of anxiety and activity. Psychopharmacology, 154, 336-342.
54. Podhorna, J., & Didriksen, M. (2004). The heterozygous reeler mouse: Behavioural phenotype. Behavioural Brain Research, 153, 43-54.
55. Risbrough, V. B., & Geyer, M. A. (2005). Anxiogenic treatments do not increase fear-potentiated startle in mice. Biological Psychiatry, 57, 33-43.
56. Rodgers, R. J. (1997). Animal models of 'anxiety': Where next? Behavioural Pharmacology, 8, 477-496; discussion 497-504.
57. Roskoden, T., Hanke, J., Yilmazer-Hanke, D., & Schwegler, H. (2005). Reduced number of CRF-containing neurons in the central amygdala correlated with enhanced locomotor activity following early postnatal corticosterone treatment in the Wistar rat. Behavioural Brain Research, 165, 221-228.
58. Ryabinin, A. E., Wang, Y. M., & Finn, D. A. (1999). Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacology Biochemistry and Behavior, 63, 143-151.
59. Sablowski, N., Pawlik, K., Ludecke, D. K., & Herrmann, H. D. (1986). Aspects of personality in patients with pituitary adenomas. Acta Neurochirurgica, 83(1-2), 8-11.
60. Sachar, E. J., Puig-Antich, J., Ryan, N. D., Asnis, G. M., Rabinovich, H., Davies, M., et al. (1985). Three tests of cortisol secretion in adult endogenous depressives. Acta Psychiatrica Scandinavica, 71, 1-8.
61. Sanchez, M. M., Noble, P. M., Lyon, C. K., Plotsky, P. M., Davis, M., Nemeroff, C. B., et al. (2005). Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biological Psychiatry, 57, 373-381.
62. Sandi, C., & Loscertales, M. (1999). Opposite effects on NCAM expression in the rat frontal cortex induced by acute vs. chronic corticosterone treatments. Brain Research, 828, 127-134.
63. Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry, 57, 925-935.
64. Schulkin, J., Gold, P. W., & McEwen, B. S. (1998). Induction of corticotropin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology, 23, 219-243.
65. Schulkin, J., McEwen, B. S., & Gold, P. W. (1994). Allostasis, amygdala, and anticipatory angst. Neuroscience & Biobehavioral Reviews, 18, 385-396.
66. Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003). The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: A review. CNS Drug Review, 9, 57-96.
67. Shepard, J. D., Barron, K. W., & Myers, D. A. (2000). Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Research, 861, 288-295.
68. Shimada, T., Matsumoto, K., Osanai, M., Matsuda, H., Terasawa, K., & Watanabe, H. (1995). The modified light/dark transition test in mice: Evaluation of classic and putative anxiolytic and anxiogenic drugs. General Pharmacology, 26, 205-210.
69. Soliday, E., Grey, S., & Lande, M. B. (1999). Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics, 104(4), e51.
70. Stevens, K. E., Bullock, A. E., & Collins, A. C. (2001). Chronic corticosterone treatment alters sensory gating in C3H mice. Pharmacology Biochemistry and Behavior, 69, 359-366.
71. Stratton, S. C., Beresford, I. J., Harvey, F. J., Turpin, M. P., Hagan, R. M., & Tyers, M. B. (1993). Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box. European Journal of Pharmacology, 250(3), R11-R12.
72. Swanson, L. W., & Simmons, D. M. (1989). Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. Journal of Comparative Neurology, 285, 413-435.
73. Thompson, B. L., Erickson, K., Schulkin, J., & Rosen, J. B. (2004). Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behavioural Brain Research, 149, 209-215.
74. van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W., et al. (2005). Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 90, 3279-3286.
75. Varghese, F. P., & Brown, E. S. (2001). The hypothalamic-pituitary- adrenal axis in major depressive disorder: A brief primer for primary care physicians. Primary Care Companion to the Journal of Clinical Psychiatry, 3(4), 151-155.
76. Wellman, C. L. (2001). Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. Journal of Neurobiology, 49, 245-253.
77. Woolley, C. S., Gould, E., & McEwen, B. S. (1990). Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Research, 531, 225-231.
78. Yehuda, R., McFarlane, A. C., & Shalev, A. Y. (1998). Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biological Psychiatry, 44, 1305-1313.
79. Yilmazer-Hanke, D. M., Wigger, A., Linke, R., Landgraf, R., & Schwegler, H. (2004). Two Wistar rat lines selectively bred for anxiety-related behavior show opposite reactions in elevated plus maze and fear-sensitized acoustic startle tests. Behavior Genetics, 34, 309-318.